Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hachimijiogan as adjunctive therapy for mild Alzheimer's disease
jRCTs071190018Completed
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of hachimijiogan in Alzheimer's disease (AD) (2 arms). Primary endpoint: ADAS-Jcog. Started Aug 2019; status: completed.
02
Drugs
hachimijiogan
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCTs071190018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071190018.